Rothmund-Thomson syndrome: Immuno-osseous challenges by Meyts, I et al.
POSTER PRESENTATION Open Access
Rothmund-Thomson syndrome: Immuno-osseous
challenges
I Meyts
1*, L De Somer
1, X Bossuyt
2, M-A Morren
3, K Devriendt
4, C Wouters
1
From 18th Pediatric Rheumatology European Society (PReS) Congress
Bruges, Belgium. 14-18 September 2011
Background
Rothmund-Thomson (RTS) syndrome is a rare autosomal
recessively inherited genodermatosis.. It is characterized
by poikiloderma, small stature, skeletal and dental
abnormalities, cataract, and an increased risk of cancer.
The syndrome is caused by mutations in RECQL4 at 8q24.
Aims
To describe the osseous and immunologic features of
three patients with genetically confirmed RTS.
Methods
Immunological investigation, x-ray imaging and bone
densitometry were performed at time of the first visit to
the combined rheumatology-immunology clinic.
Results
All patients had characteristic poikiloderma as well as
thumb anomalies. They were born dysmaturely and pre-
sented with failure to thrive.
Age at genetic diagnosis was 5y, 4y and 3y for P1, P2, P3.
Osteopenia and abnormal metaphyseal trabeculation
of bones were striking on the initial skeletal survey in all
patients. Z-scores on DXA scan were -0.1, -1.1 and -1.2
for P1, P2, P3 respectively at presentation. The presenta-
tion in P2 was dramatic with 6 fractures in upper and
lower extremities and subluxation of both radii.
All patients were suffering from recurrent chest infec-
tions. P1 had granulomatous skin inflammation following
primo VZV infection. All patients have low switched
memory B cells for age, P1 has IgG2 deficiency. P1 and
P3 have IgM deficiency. P1 and P3 have specific polysac-
charide antibody deficiency. Results are pending for P2.
All receive prophylactic antibiotics. P1 is treated with
subcutaneous immunoglobulin substitution.
Conclusion
RTS is a genodermatosis with variable clinical presentation
and course. Our observation of severe bone abnormalities
and associated immunodeficiency merits attention for
optimal management of these patients.
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